La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Kato (Hong Kong) Holdings Performance dei guadagni passati
Il passato criteri di controllo 1/6
Kato (Hong Kong) Holdings has been growing earnings at an average annual rate of 17%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 14.8% per year. Kato (Hong Kong) Holdings's return on equity is 14.8%, and it has net margins of 23.7%.
Informazioni chiave
17.0%
Tasso di crescita degli utili
14.2%
Tasso di crescita dell'EPS
Healthcare Crescita del settore | 11.3% |
Tasso di crescita dei ricavi | 14.8% |
Rendimento del capitale proprio | 14.8% |
Margine netto | 23.7% |
Ultimo aggiornamento sui guadagni | 31 Mar 2024 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Kato (Hong Kong) Holdings (HKG:2189) Is Due To Pay A Dividend Of HK$0.02
Jun 29Why Kato (Hong Kong) Holdings' (HKG:2189) Shaky Earnings Are Just The Beginning Of Its Problems
Dec 27Kato (Hong Kong) Holdings' (HKG:2189) Dividend Will Be Reduced To HK$0.022
Aug 04Kato (Hong Kong) Holdings (HKG:2189) Is Paying Out Less In Dividends Than Last Year
Jul 21Kato (Hong Kong) Holdings' (HKG:2189) Dividend Is Being Reduced To HK$0.022
Jun 28Kato (Hong Kong) Holdings (HKG:2189) Has Announced That It Will Be Increasing Its Dividend To HK$0.022
Nov 18Kato (Hong Kong) Holdings (HKG:2189) Is Increasing Its Dividend To HK$0.025
Aug 09Kato (Hong Kong) Holdings (HKG:2189) Will Pay A Larger Dividend Than Last Year At HK$0.025
Jul 13Kato (Hong Kong) Holdings (HKG:2189) Will Pay A Larger Dividend Than Last Year At HK$0.025
Jun 29Kato (Hong Kong) Holdings (HKG:2189) Will Pay A Dividend Of HK$0.02
Dec 01Kato (Hong Kong) Holdings (HKG:2189) Is Due To Pay A Dividend Of HK$0.02
Aug 21Kato (Hong Kong) Holdings (HKG:2189) Is Due To Pay A Dividend Of HK$0.02
Jun 18Should You Be Adding Kato (Hong Kong) Holdings (HKG:2189) To Your Watchlist Today?
May 30Is Kato (Hong Kong) Holdings Limited (HKG:2189) A Smart Choice For Dividend Investors?
May 04Insider Buying: The Kato (Hong Kong) Holdings Limited (HKG:2189) CEO & Executive Chairman of the Board Just Bought HK$336k Worth Of Shares
Mar 02Is Now The Time To Put Kato (Hong Kong) Holdings (HKG:2189) On Your Watchlist?
Feb 11What To Know Before Buying Kato (Hong Kong) Holdings Limited (HKG:2189) For Its Dividend
Jan 07Kato (Hong Kong) Holdings (HKG:2189) Could Be A Buy For Its Upcoming Dividend
Dec 02Ripartizione dei ricavi e delle spese
Come Kato (Hong Kong) Holdings guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
---|---|---|---|---|
31 Mar 24 | 271 | 64 | 18 | 0 |
31 Dec 23 | 303 | 77 | 22 | 0 |
30 Sep 23 | 335 | 89 | 25 | 0 |
30 Jun 23 | 372 | 108 | 33 | 0 |
31 Mar 23 | 408 | 126 | 40 | 0 |
31 Dec 22 | 393 | 119 | 35 | 0 |
30 Sep 22 | 378 | 112 | 30 | 0 |
30 Jun 22 | 349 | 105 | 22 | 0 |
31 Mar 22 | 320 | 99 | 14 | 0 |
31 Dec 21 | 306 | 95 | 16 | 0 |
30 Sep 21 | 291 | 90 | 18 | 0 |
30 Jun 21 | 274 | 85 | 18 | 0 |
31 Mar 21 | 257 | 80 | 17 | 0 |
31 Dec 20 | 236 | 70 | 14 | 0 |
30 Sep 20 | 216 | 61 | 12 | 0 |
30 Jun 20 | 206 | 54 | 12 | 0 |
31 Mar 20 | 196 | 48 | 13 | 0 |
31 Dec 19 | 190 | 45 | 19 | 0 |
30 Sep 19 | 184 | 42 | 24 | 0 |
30 Jun 19 | 180 | 40 | 29 | 0 |
31 Mar 19 | 175 | 38 | 35 | 0 |
31 Mar 18 | 158 | 36 | 36 | 0 |
31 Mar 17 | 152 | 33 | 32 | 0 |
31 Mar 16 | 144 | 31 | 32 | 0 |
Guadagni di qualità: 2189 has a large one-off gain of HK$21.8M impacting its last 12 months of financial results to 31st March, 2024.
Margine di profitto in crescita: 2189's current net profit margins (23.7%) are lower than last year (30.9%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: 2189's earnings have grown by 17% per year over the past 5 years.
Accelerare la crescita: 2189's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Guadagni vs Settore: 2189 had negative earnings growth (-49.1%) over the past year, making it difficult to compare to the Healthcare industry average (3.1%).
Rendimento del capitale proprio
ROE elevato: 2189's Return on Equity (14.8%) is considered low.